{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:04:39Z","timestamp":1760853879314},"reference-count":22,"publisher":"Baishideng Publishing Group Inc.","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2003]]},"DOI":"10.3748\/wjg.v9.i8.1840","type":"journal-article","created":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T20:32:05Z","timestamp":1444422725000},"page":"1840","source":"Crossref","is-referenced-by-count":7,"title":["Inhibition of hepatitis B virus by a novel L-nucleoside, \u03b2-L-D4A and related analogues"],"prefix":"10.3748","volume":"9","author":[{"given":"Jin-Ming","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Bridges EG, Cheng YC. Use of novel beta-L(-)-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma. Prog Liver Dis 1995;13:231-245."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2000.02129.x"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.3.496-503.2000"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.4.868"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(99)00056-X"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9071(200007)61:3<367::AID-JMV15>3.0.CO;2-A"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(96)02048-4"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280124"},{"key":"ref9","unstructured":"Chu CK, Boudinot FD, Peek SF, Hong JH, Choi Y, Korba BE, Gerin JL, Cote PJ, Tennant BC, Cheng YC. Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent. Antivir Ther 1998;3:113-121."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(95)00836-5"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1021\/jm9806749"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1021\/jm960098l"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1021\/jm970275y"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Qiu YL, Ptak RG, Breitenbach JM, Lin JS, Cheng YC, Kern ER, Drach JC, Zemlicka J. (Z)- and (E)-2-(hydroxymethylcyclopropylidene)-methylpurines and pyrimidines as antiviral agents. Antivir Chem Chemother 1998;9:341-352.","DOI":"10.1177\/095632029800900406"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1021\/jm9705723"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1021\/jm9703698"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1359-4117.2002.01035.x"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(94)90052-3"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1021\/jm990195p"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780367"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9071(200007)61:3<380::AID-JMV17>3.0.CO;2-5"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200212150-00002"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v9\/i8\/1840.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T06:50:01Z","timestamp":1567234201000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v9\/i8\/1840.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v9.i8.1840","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2003]]}}}